GPT and metabolic dysfunction-associated steatohepatitis: Patients with MASH had higher body mass index (BMI), fasting glucose, triglycerides, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels compared to those with MASLD and MASL (Table 1).